Ayala Pharmaceuticals
Presence
Ayala Pharmaceuticals is a company listed under the stock ticker AYLA (IL).
Acquisition, funding and merger involving Ayala Pharmaceuticals.
- Ayala Pharmaceuticals and Advaxis have announced they will merge (posted on October 21 2022)..
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Ayala Pharmaceuticals
- Kenneth Berlin, President and Chief Executive Officer
- Vered Bisker-Leib, Director
- Samir Khleif, Director
Create your alert
to follow the executive moves at Ayala Pharmaceuticals.
Pharmaceuticals
Ayala Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Ayala Pharmaceuticals
- News Releases - Ayala Pharmaceuticals
- News Releases - Ayala Pharmaceuticals
- Ayala Pharmaceuticals Announces Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102 in Desmoid Tumors - Ayala Pharmaceuticals
- Ayala Pharmaceuticals Announces Data on AL101 in Adenoid Cystic Carcinoma (ACC) at 2022 ASCO Annual Meeting - Ayala Pharmaceuticals
- Ayala Pharmaceuticals to Present at the 2022 Jefferies Global Healthcare Conference - Ayala Pharmaceuticals
- Ayala Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update - Ayala Pharmaceuticals
- Ayala Pharmaceuticals Announces Poster Presentation on AL101 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - Ayala Pharmaceuticals
- Events and Presentations - Ayala Pharmaceuticals
- News Releases - Ayala Pharmaceuticals
- Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma with Notch Activating Mutations at ESMO 2020 - Ayala Pharmaceuticals
- View more press releases Close
Social media about Ayala Pharmaceuticals
- Ayala Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Ayala Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Kenneth Berlin 
Call Ayala Pharmaceuticals at +972 ...
